Home/Filings/4/0001628280-21-005335
4//SEC Filing

Erlander Mark 4

Accession 0001628280-21-005335

CIK 0001213037other

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 12:24 PM ET

Size

4.7 KB

Accession

0001628280-21-005335

Insider Transaction Report

Form 4
Period: 2021-03-23
Erlander Mark
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2021-03-23$10.34/sh+965$9,98014,481 total

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1
  • filerCIK 0001651537

Filing Metadata

Form type
4
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 12:24 PM ET
Size
4.7 KB